| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in REPL over the last quarter tilts toward selling: insiders offloaded a net 79,124 shares worth roughly $1.0M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.36M | $28.13M | - | |
| CEO | 708.2K | $14.62M | - | |
| Other | 224.2K | $4.63M | - | |
| CFO | 215.9K | $4.46M | - | |
| Other | 181.0K | $3.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2019 | Colin Love72 | Chief Operating Officer | Sell | 11,250 | $17.00 | $191,250.00 | -1.0% | |
| Oct 31, 2019 | Robert Coffin61 | President and CEO | Sell | 24,250 | $17.00 | $412,250.00 | -1.0% | |
| Sep 23, 2019 | Robert Coffin61 | President and CEO | Sell | 24,250 | $17.05 | $413,462.50 | -1.0% | |
| Sep 23, 2019 | Philip Astley-Sparke47 | Executive Chairman | Sell | 14,500 | $17.05 | $247,225.00 | -1.0% | |
| Sep 23, 2019 | Colin Love72 | Chief Operating Officer | Sell | 11,250 | $17.05 | $191,812.50 | -1.0% | |
| Jul 24, 2018 | Forbion Capital Fund III Cooperatief U.A. | 10% Owner | Buy | 133,333 | $15.00 | $1,999,995.00 | +2.9% | |
| Jul 24, 2018 | Bain Capital Life Sciences Investors, LLC48 | 10% Owner | Buy | 500,000 | $15.00 | $7,500,000.00 | +21.4% | |
| Jul 24, 2018 | Hugo Alexander Slootweg | Director, 10% Owner | Buy | 133,333 | $15.00 | $1,999,995.00 | +2.9% | |
| Jul 24, 2018 | Joseph P Slattery | Director | Buy | 6,667 | $15.00 | $100,005.00 | New | |
| Jul 24, 2018 | Omega Fund IV, L.P.81 | 10% Owner | Buy | 266,667 | $15.00 | $4,000,005.00 | New |